Berho Corona Lorenzo Manuel Sells Shares of VTMX

Insider Berho Corona Lorenzo Manuel sold 1,648 shares of VTMX on June 9, 2026.

Key Points

  • Berho Corona Lorenzo Manuel sold 1,648 shares of VTMX at $3.43 each on June 9, 2026, totaling $5,652.64.
  • VTMX shares traded at $34.32; the company has seen insider selling activity recently.
  • Analysts from Barclays and UBS maintained 'buy' ratings with price targets of $41 and $39, respectively.

On June 9, 2026, Berho Corona Lorenzo Manuel sold 1,648 shares of VTMX at an average price of $3.43 per share. This sale was valued at $5,652.64 and was not part of a pre-planned trading program.

Insider Buying and Selling at VTMX

Recent insider activity at VTMX includes several sales. On June 15, 2026, Berho Corona Lorenzo Manuel also sold 48,352 shares at $3.48 each. Earlier, on June 8, Diego Berho Carranza, Chief Portfolio Officer, sold 10,000 shares at $3.44. Sergio Raul Martin Colmenares, Development & CP Manager, sold 34,239 shares at $3.42 on the same day. Additionally, Juan Felipe Sottil Achutegui, Chief Financial Officer, sold 97,488 shares at $3.49 on June 3 and 150,000 shares at $3.44 on June 2.

Analysts Set New Price Targets

Analysts have been active in setting price targets for VTMX. On May 4, 2026, Barclays maintained its 'buy' rating with a price target of $41. UBS also maintained a 'buy' rating with a target of $39 on December 17, 2025. Goldman Sachs, however, downgraded the stock to 'sell' with a target of $21 on March 25, 2025.

Bottom Line

Berho Corona Lorenzo Manuel's recent sale of VTMX shares is part of a broader trend of insider selling. While insider sales can be for various reasons, they often attract investor attention. VTMX continues to receive positive analyst coverage, with firms like Barclays and UBS maintaining 'buy' ratings. As with any 13F or insider filing, these reports are backward-looking and may not reflect current positions.

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.